Tuesday, 27 August 2013

What is fibrodysplasia ossificans progressiva?


Risk Factors

Most cases of FOP are sporadic and result from a new gene mutation. FOP is inherited as an autosomal dominant trait. Only a few multigenerational families exist, due to the low reproductive fitness. Though patterns are difficult to discern due to the rarity of the disease, FOP occurs more often in females than in males.










Etiology and Genetics

FOP is characterized by a progressive transformation of skeletal muscle and connective tissue into ectopic bone. This process of one tissue type being transformed into another is a clinical feature unique to FOP. It is similar to the formation of bone in the developing fetus and during the healing of a fracture. This normal process, called endochondral ossification, involves the formation of bone from a cartilage model. In FOP, this same process occurs in the wrong places and at the wrong time. Progenitor cells in connective tissue and skeletal muscle are transformed into endochondral bone to form a second skeleton. This process of heterotopic ossification occurs in similar anatomic and temporal patterns to that seen in the fetus, beginning in the head, neck, and shoulders and progressing caudally to the hips and distally through the limbs. It characteristically spares the face, eyes, heart, and tongue. Heterotopic ossification is also induced by tissue injury and inflammation.


The transformation process in FOP has been well characterized. A flareup begins with the appearance of a painful connective tissue swelling. T lymphocytes migrate into the skeletal muscle and cause cell destruction. B lymphocytes then proliferate around blood vessels and stimulate the formation of new vessels. The final stages include cartilage and endochondral bone formation. These stages are similar to embryonic skeletal development and early fracture healing, except for the involvement of inflammatory cells.


Bone morphogenetic proteins (BMPs) are a family of extracellular signaling proteins that regulate cell differentiation in a variety of tissues. BMPs act by binding specific receptors in the cell membrane of target cells, resulting in the activation of an intracellular signaling pathway. Activin receptor type I (ACVR1) is one type of BMP receptor found in many tissues of the body, including skeletal muscle and cartilage. Binding of BMPs to the ACVR1 receptor results in activation of the BMP signaling pathway and transcription of genes required for cartilage and bone cell differentiation.


FOP is caused by a mutation of the gene that encodes the ACVR1 receptor. The ACVR1 gene is located at chromosome band 2q23-q24. All patients with the classic features of FOP have the same R206H mutation in one copy of the gene. This mutation causes the substitution of histidine for arginine in a glycine/serine-rich domain of the receptor. Studies predict that this amino acid substitution leads to a change in the shape of the receptor that alters its sensitivity and function. FOP cells demonstrate constant activation of the ACVR1 receptor and dysregulated BMP signaling pathways, resulting in excessive cartilage and bone cell differentiation.




Symptoms

All patients with FOP are born with a characteristic malformation of the great toe. Heterotopic ossification begins in early childhood with an episode of painful soft tissue swelling, followed by metamorphosis into ectopic bone. These episodes, called flare-ups, occur intermittently throughout life, resulting in progressive fusion of the joints and spine in fixed positions and associated immobility.




Screening and Diagnosis

The clinical diagnosis of FOP is based on the presence of heterotopic ossification in characteristic anatomic patterns and the presence of the great toe malformation. Plain radiographs may also demonstrate the presence of extraskeletal bony lesions, and other minor bone malformations, including cervical spine abnormalities and tibial osteochondromas. The soft tissue swellings of FOP are often misdiagnosed as cancer; however, a biopsy is not necessary for diagnosis and will trigger a flare-up. Definitive testing for FOP is based on DNA testing of the ACVR1 gene for the specific R206H mutation.




Treatment and Therapy

At the present time, there is no medication or therapy that can stop the progressive formation of ectopic bone in FOP patients. Medical management is limited to symptomatic relief of painful flare-ups. Supportive care is important for the progressive disability resulting from spinal deformity and joint immobilization, restrictive cardiopulmonary function, recurrent pulmonary infections, hearing loss, and poor nutrition. Future therapy may involve medications that decrease ACVR1 receptor activation, in addition to the identification of affected children before the onset of heterotopic ossification.




Prevention and Outcomes

Unnecessary surgical procedures, injections, and dental procedures are contraindicated; falls and injuries should be prevented. Patients are wheelchair bound before age thirty. Progressive immobility of the chest wall leads to thoracic insufficiency syndrome and life-threatening pulmonary complications. The average life span is forty-five years.




Bibliography


Gorlin, R. J., M. M. Cohen, and R. C. M. Hennekam. Syndromes of the Head and Neck. 4th ed. New York: Oxford UP, 2001. Print.



Kaplan, F. S., E. M. Shore, and J. M. Connor. “Fibrodysplasia Ossificans Progressiva.” Connective Tissue and Its Heritable Disorders: Molecular, Genetic, and Medical Aspects. Ed. P. M. Royce and B. U. Steinmann. 2d ed. New York: Wiley, 2002. Print.



Kaplan, F. S., M. Xu, D. L. Glaser, et al. “Early Diagnosis of Fibrodysplasia Ossificans Progressiva.” Pediatrics 121.5 (2008): e1295-1300.



Lowery, Jonathan W., and V. Rosen. “Allele-Specific Interference in FOP: Silencing the FOP Gene.” Gene Therapy 19 (2012): 701–02. Print.



Schwartz, Robert A. “Fibrodysplasia Ossificans.” Medscape. WebMD, 7 May 2014. Web. 23 July 2014.



Thakker, Rajesh V., John A. Eisman, Takashi Igarashi, and Michael P. White. Genetics of Bone Biology and Skeletal Disease. London: Academic, 2013. Print.

Monday, 26 August 2013

In "The Ransom of Red Chief" by O. Henry, how does the little boy respond at first to being kidnapped?

Sam and Bill select the son of Ebenezer Dorset as their victim. After storing their provisions in a cave on the mountain, they drive their rented buggy into town and spy the boy throwing rocks at a kitten. They try to entice him into the buggy by offering him candy and a ride. The boy, whose name is Johnny, throws a piece of brick at Bill that hits him him in the eye. The men...

Sam and Bill select the son of Ebenezer Dorset as their victim. After storing their provisions in a cave on the mountain, they drive their rented buggy into town and spy the boy throwing rocks at a kitten. They try to entice him into the buggy by offering him candy and a ride. The boy, whose name is Johnny, throws a piece of brick at Bill that hits him him in the eye. The men have to struggle with Johnny to get him into the buggy; in fact, he "put up a fight like a welter-weight cinnamon bear." This means that the boy does not go willingly, nor is he convinced by the bribe they offer him.


However, once Johnny is at the camp of the kidnappers, he begins to enjoy himself. He pretends to be Red Chief, an "Indian" who has captured Hank the Trapper, played by Bill. Bill has bruises all over his shins where Johnny has kicked him. Ironically, Johnny is very happy in his captivity; he "seemed to be having the time of his life." He thinks camping out in a cave is a lark. In fact, during dinner he assures the men he doesn't want to go home at all because he doesn't have any fun there. He would much rather camp out with his friends "Snake-eye" and "Hank."


Although Johnny fights the men during his initial capture, he soon warms to the idea of camping out with the men and declares he has "never had such fun in all [his] life."

What is polydactyly? |


Risk Factors

Polydactyly can occur spontaneously (familial polydactyly) or in conjunction with a number of genetic disorders. Asphyxiating thoracic dystrophy (Jeune syndrome) is a bone growth disorder. Carpenter syndrome is an acrocephalopolysyndactyly (ACPS) disorder that affects bone growth. Ellis-van Creveld syndrome (chondroectodermal dysplasia) is a bone growth disorder involving growth hormone derficiency; the highest incidence rate of this syndrome occurs in Old Order Amish from Lancaster County, Pennsylvania. Laurence-Moon-Biedl syndrome is a mitochondrial myopathic disorder characterized by intellectual disability and possibly short stature.








Rubinstein-Taybi syndrome is a rare disorder characterized by intellectual diability and short stature. Smith-Lemli-Opitz syndrome is a disorder characterized by microcephaly (small head circumference), hypotonia (weak muscle tonus), and possible organ malformations; the highest incidence of this syndrome occurs in Caucasians of central European ancestry. Trisomy 13 (Patau syndrome) is a usually fatal disorder characterized by multiple structural and developmental abnormalities.


Familial polydactyly may occur independent of any other symptoms or disease. The highest incidence of sixth digit inheritance occurs in African Americans. In those rare instances where polydactylism causality cannot be definitively attributed to genetic abnormality, it is hypothesized that womb abnormality or exposure to toxins may be contributing factors.




Etiology and Genetics

Although it can occur independent of genetic factors, polydactyly is most commonly a heritable, autosomal dominant trait involving a single gene that is capable of causing several variations in expression. Therefore, inheritance is not gender linked and does not require that both parents have the trait. It most likely occurs as the result of duplication of a single embryologic bud.


Incidence rate for polydactyly of the hand is approximately 1 per 1,000 births. It is the most common hand anomaly and occurs most frequently as preaxial (thumb) polydactyly in those of Asian ancestry who have the trait and as postaxial (little finger) polydactyly in those of African ancestry who have the trait. It does not usually occur bilaterally.


Incidence rate for polydactyly of the foot is approximately 1 to 2 per 1,000 births. In approximately 50 percent of all cases, it occurs bilaterally although not necessarily symmetrically. In approximately 33 percent of all cases, it occurs in conjunction with polydactyly of the hand.


Incidence of fused extra digits indicates the concomitant occurrence of polydactyly and syndactyly (fusion of digits) and is termed polysyndactyly.




Symptoms

The only symptom of polydactyly is the presence of one or more extra digits. The presence of other symptoms may indicate the possibility of a concomitant genetic disorder.




Screening and Diagnosis

Screening consists of obtaining a comprehensive medical history and performing chromosome studies. Diagnosis is possibly via fetal sonogram and is immediately apparent at birth. Radiographic evaluation may be necessary to determine the extent of possible skeletal involvement and to confirm that there is no underlying deformity. Other tests that may be used to confirm the diagnosis are enzyme tests and metabolic studies.




Treatment and Therapy

Treatment most often involves surgery, the extent of which is dependent upon the degree of bone, ligament, and tendon involvement. In order to reduce the risk of anesthesia yet allow for the maximum potential for remodeling, surgical excision usually occurs when a baby is approximately one year old.


Standard practice for correction of a “floppy digit,” one attached only by soft tissue, is application of suture ligature while the baby is in the hospital nursery. This practice is not recommended, however, if the extra digit has metacarpal/metatarsal duplication and/or residual cartilage, due to the risk of future deformity.


Extensive surgical intervention may require subsequent stabilization of the joint area via short-term casting and maximization of function via physical therapy. Additional surgery may be required during childhood to prevent or correct growth deformity.




Prevention and Outcomes

There is no known means of prevention for spontaneously occurring polydactyly. Possible prevention of polydactyly that occurs in conjunction with genetic disorders would require genetic screening and counseling of prospective parents. The prognosis for isolated polydactyly is extremely favorable with surgical excision.




Bibliography


Barnhill, Raymond L., and A. Neil Crowson. Textbook of Dermatopathology. 3rd ed. New York: McGraw, 2010. Print.



Holmes, Lewis B. Common Malformations. New York: Oxford UP, 2012. Print.



Hosalkar H. S., Spiegel D. A., and Davidson R. S. “Toe Deformities.” Nelson Textbook of Pediatrics. 19th ed. Ed. R. M. Kliegman, et al. Philadelphia: Saunders, 2011. Print.



Kumar, Praveen, and Barbara K. Burton. Congenital Malformations Evidence-Based Evaluation and Management. New York: McGraw, 2011. Digital file.



Malik, S. "Polydactyly: Phenotypes, Genetics and Classification." Clinical Genetics 85.3 (n.d.): 203–12. Biological Abstracts. Web. 7 Aug. 2014.



McGlamry, Dalton, et al. McGlamry’s Comprehensive Textbook of Foot and Ankle Surgery. 3rd ed. Philadelphia: Lippincott, 2001. Print.



Tickle, C. “Embryology.” The Growing Hand: Diagnosis and Management of the Upper Extremity in Children. Ed. A. Gupta, S. P. J. Kay, and L. R. Scheker. London: Mosby, 2000. Print.

Sunday, 25 August 2013

What were Brutus's and Cassius's motives for killing Caesar?

Cassius appears to envy Julius Caesar, while Brutus is fearful for the Roman Republic. Cassius points out that Caesar has grown too powerful, though he is not more worthy than anyone else: “Brutus and Caesar: what should be in that 'Caesar'? / Why should that name be sounded more than yours?” Cassius condemns Caesar’s weakness as a human, emphasizing that he is nothing more than a man who may aspire to be dictator. Caesar describes...

Cassius appears to envy Julius Caesar, while Brutus is fearful for the Roman Republic. Cassius points out that Caesar has grown too powerful, though he is not more worthy than anyone else: “Brutus and Caesar: what should be in that 'Caesar'? / Why should that name be sounded more than yours?” Cassius condemns Caesar’s weakness as a human, emphasizing that he is nothing more than a man who may aspire to be dictator. Caesar describes Cassius’s ambition and jealousy: “Such men as he be never at heart's ease / Whiles they behold a greater than themselves.”


Brutus, on the other hand, cares about Caesar: “I know no personal cause to spurn at him, / But for the general.” However, he worries about how power will corrupt Caesar and believes it necessary to nip his aspirations in the bud. At Caesar’s funeral, Brutus emphasizes how much he loved and mourns for Caesar: “Not that I loved Caesar less, but that I loved Rome more.” He slew Caesar for his ambition, which he considered a threat to Rome. As far as Brutus is concerned, a monarchy would make them all slaves.


Both Cassius and Brutus worried about Caesar’s growing popularity. Caesar was a proud and strong-willed man, so their fears were very valid. Their conflicting motives result in some irreconcilable contradictions in their coup, which ultimately falls to Mark Antony and Octavius Caesar. Octavius would usher in the Roman Empire, the exact fate Brutus was hoping to avoid.

What is chancroid? |


Definition

Chancroid is a sexually transmitted disease (STD) caused by the bacterium
Haemophilus ducreyi. The disease, which causes painful sores on
the genitalia, is most common in developing countries. Chancroid increases the
risk of infection by other sexually transmitted pathogens,
including the human immunodeficiency virus.











Causes

Chancroid is caused by H. ducreyi, a sexually transmitted,
gram-negative, facultatively anaerobic, coccobacillus. The bacterium grows in
chains and requires hemin for growth. The bacterium needs breaks in the host’s
epidermal layer to initiate infection.




Risk Factors

Chancroid is more common in uncircumcised males and in persons who have sex with sex workers in developing countries.




Symptoms

The initial appearance after infection is a reddened, raised lesion on the
genitalia three to five days after exposure, although the infection can appear in
as little as one day or in as many as fourteen days. Within twenty-four hours, the
lesion converts to a painful, soft-edged ulcer with irregular borders that often
secrete pus. Men often have a single ulcer and women usually have four or
more.


Swollen, painful lymph nodes are also present in approximately one-half of
cases. These swollen nodes, called buboes, may rupture and form abscesses
that drain pus. Women tend to have milder symptoms than men, and more than 50
percent of infected women are asymptomatic. Self-inoculation with the fingers can
transfer the bacteria, so that chancroid ulcers appear at other locations on the
body, especially on the conjunctiva, a membrane that covers the eye and lines the
inner surface of the eyelid.




Screening and Diagnosis

Chancroid can be confused with the hard chancre of syphilis, but
chancre, unlike chancroid, is usually painless, does not
exude pus, and heals on its own within six weeks. Samples from a skin ulcer can
also be looked at with dark-field microscopy; a lack of visible spirochetes
indicates chancroid rather than a syphilitic chancre. Definitive diagnosis depends
on isolating the bacteria and growing it on one of three specialized media,
although this test is only 80 percent effective in diagnosis.




Treatment and Therapy

Chancroid responds well to antibiotics. The most common regimen is
a single dose of azithromycin. Other possible treatments include a single
intramuscular injection of ceftriaxone, oral ciprofloxacin twice daily for three
days, or erythromycin four times a day for a week. Infections in uncircumcised
males are more resistant to antibiotic therapy. Sex partners of infected persons
are also treated, even if they show no signs of chancroid.




Prevention and Outcomes

The use of latex condoms decreases the likelihood of infection. Infection does not cause lasting immunity, and no effective immunizations have been developed.




Bibliography


Klausner, Jeffrey D., and Edward W. Hook III. Current Diagnosis and Treatment of Sexually Transmitted Diseases. New York: McGraw-Hill, 2007.



Larsen, Laura. Sexually Transmitted Diseases Sourcebook. Detroit: Omnigraphics, 2009.



Murphy, T. F. “Haemophilis Infections.” In Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, edited by Gerald L. Mandell, John E Bennett, and Raphael Dolin. 7th ed. New York: Churchill Livingstone/Elsevier, 2010.



Spinola, Stanley M., Margaret E. Bauer, and Robert S. Munson, Jr. “Immunopathenogenesis of Haemophilus ducreyi Infection (Chancroid).” Infection and Immunity 70 (2002): 1667-1676.



Workowski, Kimberly A., and Stuart M. Berman. “Diseases Characterized by Genital Ulcers.” Morbidity and Mortality Weekly Report 55 (2006): 14-30.

What is pharmacy? |


Science and Profession

Traditionally, pharmacy was confined to the distribution and dispensation of medications, but modern pharmacists have become recognized drug experts. The concept of pharmaceutical care promises to change pharmacy practice for the public’s benefit.



Pharmacy has always been primarily a retail practice. In the early days of the profession, physicians would often choose not to prepare medications for their patients, instead referring them to apothecaries, who would receive the prescriptions and then prepare and dispense them. A patient who was familiar with the symptoms of his or her ailment might choose to return to the apothecary to seek another course of this medication. Recognizing that many problems responded well to standardized medicinal formulas, many apothecary shops began to sell ready-made products to accommodate patients who chose to seek care from the pharmacist rather than the physician. A similar situation exists in modern times with over-the-counter medications, which are available without a prescription.


Until the 1970s, basic pharmaceutical practice changed very little. Physicians continued to devote themselves to the diagnosis and treatment of patients, and pharmacists continued to concentrate on dispensing pharmaceutical products. By this time, most of the collection and preparation (compounding) phases of the medication-developing process were being performed by the suddenly expanding pharmaceutical industry. Most medications arrived at the pharmacy in a ready-to-dispense form, such as a tablet, capsule, elixir, syrup, suppository, or ointment. This trend has progressed to the point that fewer than 1 percent of prescriptions require compounding by the pharmacist.


Most people have some understanding of pharmacy and pharmacists, usually through visits to the local drugstore. In this setting, pharmacists practice what is known as retail or community pharmacy. For many customers, it is unclear whether the pharmacist is a businessperson or a health-care professional; in fact, the answer is both. On one hand, a pharmacy often sells merchandise that many people associate with a variety store, such as pens, greeting cards, gift items, and beauty products. On the other hand, a pharmacy also has a license to sell something no variety store can: prescriptions, such as antibiotics for infections, pain medication for broken bones, or medication for high blood pressure to help prevent a stroke or heart attack.


Modern retail pharmacists operate and manage complex businesses. Pharmacists in this setting have additional challenges, such as personnel management, the organizational structure of the pharmacy, and the general focus of the business. Unrecognized activities may involve location analysis and selection, obtaining loans to purchase and operate the business, and store design. The pharmacist must evaluate computer systems for the purposes of dispensing medicine, controlling inventory, reordering stock, and interfacing with insurance companies for payment.


Not all retail pharmacy activity occurs in a community-based store. Many companies have founded large conglomerates called chain pharmacies. Occasionally, these chain stores may resemble independent community stores, but they still share common ownership. Most people are familiar with typical chain pharmacies within supermarkets and discount stores. Retail sales of prescription medicines have become increasingly available on the Internet as well.


Pharmacies in certain other practice sites, such as hospitals, are associated with the dispensation of many varied and highly complex medications. The medications dispensed in a hospital cannot be given to the patient for self-administration. Such medications include intramuscular or intravenous injections, implantable drug reservoirs, beads containing drugs, and medications requiring close observation of the patient. Hospital practice places a unique demand on the pharmacist to be a resource for drug information. Specialized pharmacists may become members of health-care teams where they provide a service to improve patient care rather than supplying a product.


During the 1980s, the insurance industry in the United States reformed payment methods for hospitals, trying to reduce the time that each patient remains in the hospital. The goal was to minimize cost by allowing the patient to recover at home. This policy reduced expensive payments to hospitals and shifted the expense to less costly home health care. Pharmacy’s ability to provide sophisticated medications in this setting allows the patient to stay at home and has created a growing segment of practice for some pharmacists.


Pharmacists are not limited to the practice types or settings mentioned above. Large pharmaceutical-manufacturing firms also employ many pharmacists in sales, marketing, management, and product development and manufacturing positions. Some pharmacists direct clinical research efforts, while others perform quality assurance or market research or hold positions in upper management.


One career track with tremendous significance to the profession is pharmacy education, a process that has seen many changes. Historically, European apothecaries used an apprenticeship system with no requirement for formal education; in contrast, modern pharmacists are well educated, often having more than 150 college-credit hours at graduation. After graduation, many pharmacy students will choose further study for an advanced degree. These degrees may focus on management (master of business administration, master of hospital pharmacy), academic work (master of science, doctor of philosophy), or postgraduate clinical studies (doctor of pharmacy). Traditionally, after completion of an advanced degree, most pharmacists join faculties at colleges of pharmacy. Others are recruited by institutional and corporate employers who find that such advanced training provides employees with skills that are beneficial to company operations.


The pharmacy student must complete an extensive application process to gain entry into a college of pharmacy. In addition to good grades, applicants usually must score well on the Pharmacy College Admission Test (PCAT), although this test is not required by all schools. Generally, an applicant must have a minimum of sixty-five hours of prepharmacy education. In the United States, required courses include English composition, general and organic chemistry, general biology (or botany and zoology), college physics, college algebra and trigonometry, principles of accounting, American history, principles of economics, and electives in the humanities and behavioral or social sciences.


One emerging area of pharmacy practice is the provision of clinical services. Clinical pharmacists are high-level consultants and experts on drug therapy and related issues. Many conduct daily patient rounds with physicians and other health-care providers. These clinical specialists review medication orders for appropriateness, verify proper doses, inform nurses of special issues when giving the medication, recommend laboratory tests and other monitoring procedures, and assess the outcome of treatment with the physician.


Once, most clinical specialists were associated with general internal medicine services. Then the need for clinical pharmacy services in other areas became apparent. To serve these patients properly, pharmacists established specialty practices. Recognized specialty areas in pharmacy include pediatrics, geriatrics, nutrition, drug information, ambulatory care, critical care, family medicine, surgery, cardiology, oncology, nuclear medicine, mental health, and pharmacokinetics, a specialty unique to pharmacists. Pharmacokinetics is a branch of pharmacology that studies what happens to a medication when it enters the body. These practitioners help choose the best dose of a medication in order to optimize clinical outcomes.


The increasing demands for enhanced services and the growing complexity of the tasks required to provide clinical services resulted in a need for further training. Many pharmacy specialists undergo residency training to provide this additional proficiency. In the United States, the Board of Pharmacy Specialities established credentials to allow pharmacists to become board certified within many of these specialty areas. Nonspecialized residency training is available in general hospital pharmacy practice. The hospital is becoming a complicated practice site that requires unique knowledge; this type of training addresses the particular needs of pharmacists in hospital practice.


A lesser-known area of practice for pharmacists is clinical research. The pharmacist may serve as the principal investigator or as a research coordinator for another investigator. The research may address questions about drugs already on the market, evaluate new treatments, or gather information about drug-related problems. In the United States, clinical research usually serves to provide the background material required by the Food and Drug Administration for a pharmaceutical manufacturer to sell a new medication. Results of this research are published in medical and pharmacy journals so that interested professionals have easy access to this new information and can apply it to patient care.




Diagnostic and Treatment Techniques

Pharmaceutical care involves four major functions: curing disease, eliminating or reducing a patient’s symptom complex, arresting or slowing a disease process, and preventing a disease or its symptom complex. A pharmacist works with other professionals to design, carry out, and monitor a therapeutic plan that will produce specific therapeutic outcomes for the patient. These activities involve three major functions: identifying potential and actual drug-related problems, preventing potential drug-related problems, and resolving actual drug-related problems. This concept was conceived in the late 1980s by the nationally noted pharmacy educators Charles D. Hepler and Linda H. Strand, who recognized that pharmaceutical care is applied on three distinct levels: primary (outpatient and community pharmacies), secondary (acute care hospitals, skilled nursing facilities, home health care, and specialized care programs, such as oncology and pain control), and tertiary (inpatient critical care and teaching medical centers). Each level of practice demands specialized services from the pharmacist.


The specifics of pharmaceutical care have been described by noted pharmacists William E. Smith and Katherine Benderev as the sum of all pharmaceutical services, both clinical and nonclinical, that are required and received by a patient. The provision of pharmaceutical care means that the pharmacist is responsible for a patient’s achievement of the desired clinical outcome secondary to the use of medications. Inherent in this idea are the basic functions of the pharmacist common to all levels of care: developing and using a patient's medication profile; interpreting, questioning, clarifying, verifying, and validating all drug-related orders; providing a safe and efficient drug-dispensing system; monitoring drug therapies for safety, efficacy, and desired clinical outcome; screening for drug allergies, drug interactions, and concomitant drug use; detecting and reporting drug allergies and adverse reactions; recommending initial or alternative drug therapies; responding to drug information requests from physicians, nurses, and patients; teaching health-care providers and patients about drug use; obtaining medication histories by interviewing patients; assisting in the selection of the drugs of choice and dosage forms; conducting drug-use evaluations in order to gauge the appropriateness of drug use and the achievement of desired therapeutic outcomes; and applying pharmaceutical principles for selected drug therapies.


Pharmacy practice in a retail setting primarily stresses filling prescriptions, but many activities behind the scenes also help the patient. In addition to buying safe and reasonably priced products, the pharmacist must maintain a patient profile, which includes data about the patient's allergies, other medications, and other relevant information. The pharmacist uses the system to screen for drug interactions, to avoid potential allergic reactions, and to ensure that the patient receives proper doses of the medication.


Traditionally, patient education by pharmacists has consisted of a brief discussion augmented by precaution labels on prescription bottles. Pharmacists and other health-care professionals have since recognized the importance of more thorough patient education in achieving optimal results using medications. Methods include one-on-one counseling, audiovisual programs, preprinted or computer-generated handouts, and other specific information sources. Some retail pharmacists use their computer systems to send refill reminders, allowing pharmacists to assist physicians in their efforts to ensure that people with chronic problems are treated adequately. Hospital-based pharmacists may implement detailed discharge counseling for patients returning home in order to review treatment plans or answer questions about medications unfamiliar to the patient.


Many pharmacists perform a very valuable service in nursing homes and long-term care facilities by evaluating patients’ medication regimens for problems. Elderly patients often use six or more medications, making them more prone to dangerous drug interactions. They may also have many illnesses, making them more sensitive to the adverse effects of medications. Pharmacists assess whether chronic conditions are being controlled, whether medications are being stored and dispensed properly, and whether efforts to ensure the patient’s safety are adequate. The latter activity may include recommendations to stop the use of a medication because of side effects, drug interactions, or toxicity. Also, the pharmacist may recommend laboratory tests to monitor drug therapy.


One area where pharmacy practice is expanding is hospital practice. In the United States in the 1960s, the pharmaceutical-manufacturing process began to see radical growth, with both the numbers and the complexity of medications increasing steadily. Hospitalized patients place unique demands on pharmacists for specialized services. These pharmacists maintain their control and responsibility for dispensing medication, yet their role has extended into being part of the drug decision-making process. A simple example is a change in the traditional role of controlling medication inventory. The hospital pharmacist will establish and use a formulary, a list of medications approved for use in the hospital. Formularies control medication costs by preventing the purchase of unneeded products and placing restrictions on the use of expensive or dangerous medications. The pharmacist helps make complex decisions, such as determining the proper doses of highly toxic medications. Since hospitalized patients are very ill, watching for potential allergic reactions and side effects is very important. For cases in which treatment decisions are unclear, the pharmacist may aid the physician in selecting a treatment.


Often, hospitalized patients require special methods for the administration of medication. Pharmacists need to be knowledgeable about intramuscular and intravenous routes of administration. Intravenous medications may require complex mixing and preparation. These products must remain sterile, with no bacteria present, and may have special storage or handling requirements. Frequently, intravenous medication is given over a fixed amount of time; therefore, the pharmacist must be familiar with the infusion pumps that regulate the amount of solution dispensed over a given period. Many medications also require specialized tubing called catheters for administration. The pharmacist plays a central role in addressing any special needs of patients requiring complex medications.


All these activities require the pharmacist to work closely with other professionals in the hospital. Frequently, the pharmacist will work with nurses to ensure proper administration and timing of doses or to monitor the patient for side effects. Laboratory personnel need to understand that medications may affect certain laboratory tests. In addition, laboratory technicians may draw blood from the patient to check the concentrations of many types of medication. Proper timing of the sample collection is very important when considering making changes to the patient’s drug therapy.




Perspective and Prospects

Pharmacy is a unique profession whose origins can be traced to the thirteenth century, when the Holy Roman emperor Frederick II issued an edict to separate the professions of pharmacy and medicine. Pharmacy became responsible for the preparation and dispensation of medications, and medicine became responsible for the diagnosis and treatment of the patient.


No professional practice is without change. Pharmacy practice evolved from the gathering, extraction, and preparation role of the apothecary to the contemporary role of medication distribution. Now, with the complexity of drug therapies increasing rapidly as new medications enter the market, physicians are becoming increasingly dependent on pharmacists to keep them informed of new developments, and pharmacists have become more active in dealing with patients and their physicians. Pharmaceutical care is a natural extension of this evolution, in which the pharmacist’s role becomes more patient centered rather than focusing on a product. The tenets of pharmaceutical care promise to become deeply ingrained in the practice of pharmacy, replacing the dated idea that a pharmacist's only role is to dispense medications.




Bibliography


Allen, Loyd V., Jr., and Howard C. Ansel. Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems. 10th ed. Baltimore: Lippincott, 2014. Print.



Brown, Thomas R., ed. Handbook of Institutional Pharmacy Practice. 4th ed. Bethesda: Amer. Soc. of Health-System Pharmacists, 2006. Print.



Dranove, David. The Economic Evolution of American Health Care: From Marcus Welby to Managed Care. Princeton: Princeton UP, 2002. Print.




Effective Pharmacy Management: A Comprehensive Presentation of Practical Management Techniques for Pharmacies. 8th ed. Alexandria: NARD, 1996. Print.



Gable, Fred B. Opportunities in Pharmacy Careers. New York: McGraw, 2003. Print.



Generali, Joyce A., and Christine A. Berger. Quick Review: Pharmacy. 13th ed. New York: McGraw, 2006. Print.



Hawthorne, Fran. The Merck Druggernaut: The Inside Story of a Pharmaceutical Giant. Hoboken: Wiley, 2003. Print.



"Pharmacists." Occupational Outlook Handbook. US Bureau of Labor Statistics, 8 Jan. 2014. Web. 19 Feb. 2015.



"The Pharmacy Profession." American Pharmacists Association. Amer. Pharmacists Assn., n.d. Web. 19 Feb. 2015.



Pisano, Douglas J. Essentials of Pharmacy Law. Boca Raton: CRC, 2003. Print.

How are tobacco products advertised?


The “Joe Camel” Campaign

Of all the advertising campaigns launched by the tobacco industry, R. J. Reynolds Tobacco Company’s marketing for Camel brand cigarettes was by far the most notorious and controversial. In 1988, in an attempt to create “replacement smokers” for those long-term smokers who were sick and dying, R. J. Reynolds introduced the enormously popular and youth “friendly” animated character Joe Camel. An engaging, wisecracking, and easygoing character, “Old Joe” was an instant success among young people. Few people realize that R. J. Reynolds’s Joe Camel was a nod to the Durham bull, a similarly popular anthropomorphic character at the turn of the twentieth century. The Durham bull advertised roll-your-own cigarettes by rebelliously kicking up its heels and making humorous remarks.




Through R. J. Reynolds’s marketing campaign, Joe Camel was popularized on billboards and in magazines and newspapers, which became saturated with the Joe Camel image. The character was selling not only Camel cigarettes but also a huge amount of Joe Camel paraphernalia—everything from T-shirts, to baseball caps, to underwear.


In 1991, the American Medical Association sparked debate when it published a study revealing that 90 percent of six-year-old children who were surveyed could recognize and identify Joe Camel, roughly the same percentage who could recognize and identify Mickey Mouse. By contrast, only 67 percent of adults surveyed could identify Joe Camel and directly associate the character with cigarettes.


After filing a lawsuit against R. J. Reynolds for deceptive advertising practices and liability, a San Francisco law firm later revealed an astronomical spike of several hundred percent in revenue from youth market shares between 1988 and 1992 that was specifically attributable to the Joe Camel advertising campaign. In 1997, following public outcry and after the US Congress threatened stricter legislation, R. J. Reynolds settled the lawsuit, agreeing to terminate Joe Camel-related advertisements and agreeing to pay the State of California $10 million to fund antismoking education for youth.


Shortly thereafter, R. J. Reynolds changed its ad campaign by replacing Joe Camel the cartoon character with an image of a true camel, an image that was designed to appeal to adults and an image that still represents Camel cigarettes.


In the end, though, it was the phenomenal success of the Joe Camel advertising campaign that did more than anything else to incense and inflame the public. The ad campaign encouraged public, school, and legislative support for subsequent antismoking campaigns around the United States.




Legislating Deceptive Tobacco Advertising

In 1900, only one in 100 Americans smoked, but that percentage soon rose. During World War I, smoking became immensely popular in both the United States and in Europe, in part because the US military distributed free branded cigarettes to its troops. By the 1930s, the Federal Trade Commission began regulating the false advertising claims made by tobacco companies. Throughout the nineteenth and early twentieth centuries, it had been commonplace for tobacco products to be advertised by doctors and surgeons, who claimed that smoking had all-around health benefits.


Beginning in 1920, tobacco brands, especially Lucky Strike, began advertising campaigns that targeted women, appealing to American women’s newfound status as “liberated” voters after the passage of the Nineteenth Amendment to the US Constitution (1920). The ads promised women that smoking would make them more slender, trim, and attractive, a claim repeated fifty years later with the branding of Virginia Slims cigarettes.


The 1930s witnessed en masse the first detrimental fallout of smoking’s ever-growing popularity, as doctors began treating huge numbers of patients for lung cancer, a disease otherwise rarely seen. Increasing numbers of medical reports and studies worldwide began to draw direct correlations between the upsurge in smokers and the spike in certain kinds of cancer.


Smoking was further popularized during World War II, when free cigarettes were provided to the troops, as they were during World War I. Also, tobacco companies continued to deny medical reports, and their ads continued to portray smoking as healthy. Hollywood similarly intensified the glamorous appeal of smoking in its films. Consequently, by 1950, approximately 50 percent of American adults smoked cigarettes.


After more than a decade of continued research that further linked smoking and cancer, the US Office of the Surgeon General (in 1964) proclaimed smoking to be hazardous to one’s health and to be a direct cause of lung cancer. In 1965, Congress passed the Cigarette Labeling and Advertising Act, which required cigarette manufacturers to place a warning label on each pack of cigarettes. The first label warned consumers that cigarette smoking “might” be hazardous to their health; in 1969, Congress passed additional legislation, the Public Health Cigarette Smoking Act, which required the warning label on cigarettes packs to be more definitive: “Warning: The Surgeon General Has Determined That Cigarette Smoking Is Dangerous to Your Health.” The act also banned all advertising for cigarettes on television and radio.




Big Tobacco Master Settlement Agreement

Throughout the 1970s and 1980s, scientific studies continued to confirm the harm of tobacco products, yet the tobacco industry continued to deny this fact in its advertising. By the 1990s, with escalating numbers of lawsuits against the tobacco industry for fraudulent misrepresentation, wrongful death, criminal negligence, and criminal liability, an increasing number of cases were decided in favor of injured and, oftentimes, deceased smokers. Moreover, as enormous amounts of taxpayer dollars were being used to treat sick and dying smokers, state attorneys general began to sue tobacco companies to recoup lost revenue from state budgets. As juries awarded plaintiffs ever larger settlements, the tobacco industry began to search for a way to stop the increasing litigation.


Finally, in 1998, R. J. Reynolds, Brown and Williamson, and Philip Morris (three major entities of what came to be called Big Tobacco) were bound to the Master Settlement Agreement (MSA), the largest financial settlement in US history. In addition to severely restricting tobacco advertising, the MSA mandated annual Big Tobacco payments of millions of dollars to state governments for ongoing governmental efforts to control tobacco use, especially among youths. The MSA also led to widespread antismoking advertising campaigns, such as the Truth campaign, which encouraged youth to stop or avoid smoking.


The MSA also made illegal all advertising and selling of tobacco products to any person younger than age eighteen and made it illegal to use any cartoon or animation to advertise tobacco products. This provision would ensure against the recurrence of any marketing campaign reminiscent of the Joe Camel campaign that had targeted children in earlier decades. The MSA additionally placed Big Tobacco advertising under the regulation and control of the US Food and Drug Administration, a provision later reinforced with congressional legislation.


E-cigarettes, which deliver nicotine by vaporizing a liquid solution containing it, are not covered by the laws restricting tobacco advertising, and the age restrictions also do not apply. The debate about advertising nicotine products to young people has therefore continued into the 2010s, with a 2015 study finding that adolescents age thirteen to seventeen were more likely to express an intention to try e-cigarettes after exposure to e-cigarette advertising. Another study, from the University of Pennsylvania, found that e-cigarette advertising was also likely to make smokers and former smokers crave tobacco.




Bibliography


Califano, Joseph, Jr. High Society: How Substance Abuse Ravages America and What to Do About It. New York: Public Affairs, 2007. Print.



Crawford, Elizabeth Crisp. Tobacco Goes to College: Cigarette Advertising in Student Media, 1920–1980. Jefferson: McFarland, 2014. Print.



"E-Cigarette Advertising Makes One Crave... Tobacco? Surprising Findings by Penn Researchers." Annenberg School for Communication. U of Pennsylvania. Web. 27 Oct. 2015.



Farrelly, Matthew C., et al. "A Randomized Trial of the Effect of E-cigarette TV Advertisements on Intentions to Use E-cigarettes." American Journal of Preventive Medicine 49.5 (2015): 686–93. Print.



Hudson, David, Jr. Smoking Bans. Philadelphia: Chelsea House, 2004. Print.



Hyde, Margaret. Know About Smoking. New York: Walker, 1995. Print.



White, Larry. Merchants of Death: The American Tobacco Industry. New York: Random House, 1991. Print.



Williams, Rodger. At Issue: Teen Smoking. Farmington Hills: Greenhaven, 2009. Print.

Friday, 23 August 2013

What is pericarditis? |


Definition

Pericarditis is the irritation and swelling of the pericardium, the two-layered
sac that envelops the heart. Pain is caused when the inflamed layers rub together
or against the heart. The inflammation may in turn cause fluids to build up within
the sac. Complications include cardiac tamponade (excessive fluid buildup that squeezes the heart)
and constrictive pericarditis (scarring and stiffening of the pericardial sac).











Causes

Most often, pericarditis is caused by a viral
infection such as influenza, meningitis,
mumps, infectious mononucleosis, intestinal tract
disorder, or complications from acquired immunodeficiency syndrome.
Bacterial pneumonia, meningitis, or influenza; other bacterial
infections such as empyema, tuberculosis,
or skin and wound diseases; and fungal infections can also spread to
the pericardium and cause inflammation. Pericarditis may also be related to
cancer, chest trauma (including surgery), kidney failure, autoimmune disease, and
radiation therapy. Often the cause is unknown.




Risk Factors

Anyone can develop pericarditis; however, the condition is most common in men age twenty to fifty years. Children younger than four years of age are more apt to develop bacterial pericarditis. After an acute episode, 15 to 30 percent of people will have a recurrence; some will develop chronic pericarditis.




Symptoms

Pericarditis caused by a virus typically comes on suddenly and is short-lived, whereas bacterial pericarditis may develop gradually. Sharp chest pain is the most common symptom, although some people report dull pain or pressure; chronic episodes can be painless. The neck, left shoulder, back, and abdomen may also be affected, and pain may worsen with deep breathing and coughing or when lying flat; the pain may ease when sitting upright or bending forward. Shortness of breath is also common, as is a dry cough, fatigue, an increased heart rate, and a fever. In cases of constrictive pericarditis, the legs and ankles may swell; with cardiac tamponade, blood pressure levels may drop.




Screening and Diagnosis

The affected person’s symptoms, especially from any recent flulike infections, are important in the diagnosis. During the physical examination, the clinician will use a stethoscope to listen for the scratchy sound of the pericardium rubbing against the heart and for other signs of fluid buildup. A chest radiograph, echocardiogram, and computed tomography scan can confirm fluid buildup or other signs of pericardial damage. Cultures of the blood and pericardial fluid can detect bacterial or fungal infections.




Treatment and Therapy

Treatment generally depends on the underlying cause. Pericarditis caused by a
virus usually resolves within three weeks; affected persons are advised to rest
and are given medications to relieve pain and reduce inflammation. Persons who do
not respond to this regimen may be given corticosteroids or colchicine. Antibiotics
or antifungal medications are also prescribed for bacterial pericarditis. Those
with fluid buildup or other complications are typically hospitalized for
observation and further testing. Fluids may be drained from the pericardial sac,
which requires local anesthetic. For persons with chronic or constrictive
pericarditis, part or all of the pericardium may be surgically removed.




Prevention and Outcomes

Untreated bacterial pericarditis can be life-threatening. Prompt medical treatment and follow-up can help to prevent complications or a second attack.




Bibliography


Berger, John. “Pericarditis, Bacterial.” Available at http://emedicine.medscape.com/article/891369-overview.



Spodick, David H. The Pericardium: A Comprehensive Textbook. New York: Marcel Dekker, 1997.



Sydell and Arnold Miller Family Heart and Vascular Institute. Pericarditis Guide. Cleveland, Ohio: Cleveland Clinic, 2009. Available at http://my.clevelandclinic.org/documents/heart/pericarditis_treatment_guide.pdf.



Zipes, Douglas P., et al., eds. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 7th ed. Philadelphia: Saunders/Elsevier, 2005.

What are the psychological theories of deviance? Provide examples for each theory.

There are three basic types of psychological theory applied to deviant behavior:The first is psychodynamic theory, originally based on Freudian psychoanalysis (though it has moved beyond this), on which it is not actually deviant behavior that needs to be explained, but conforming behavior. In psychoanalytic theory, what we call "deviance" is really just a reversion to our innate evolutionary drives (such as hunger and lust) that have been suppressed by civilization and social norms....

There are three basic types of psychological theory applied to deviant behavior:

The first is psychodynamic theory, originally based on Freudian psychoanalysis (though it has moved beyond this), on which it is not actually deviant behavior that needs to be explained, but conforming behavior. In psychoanalytic theory, what we call "deviance" is really just a reversion to our innate evolutionary drives (such as hunger and lust) that have been suppressed by civilization and social norms. This theory probably makes the most sense for weird impulsive crimes like indecent exposure; while rationally this behavior does not make much sense, it is explicable in terms of normal inhibitions being suddenly overridden by a very powerful sex drive.

The second is cognitive development theory, which is generally based on Kohlberg's theory of human moral development. According to this theory, humans normally develop through multiple stages of moral reasoning, starting from very simplistic reward-punishment reasoning and rising up to following social norms and ultimately to reasoning according to abstract principles. The cognitive development theory of deviance says that some individuals are delayed or restrained in this development, and so persist at a lower stage of moral development and engage in behaviors that more fully-developed individuals recognize as immoral. This theory probably applies best to white-collar crimes, which are typically committed by intelligent high-functioning psychopaths. Unlike more low-functioning psychopaths, these individuals can often restrain their impulsive behavior; but they are still motivated primarily by their own self-interest, and concerned with avoiding criminal behavior only insofar as it prevents them from being punished. Their behavior is in this sense rational, even though it is not ethical. It is as though they are stuck at the lowest level of moral development, in which only reward and punishment are important.

Finally there is learning theory, on which deviant behavior is actually its own sort of social norm that people acquire by living in a subculture that rewards or encourages that sort of behavior. According to this theory, individuals observe others engaging in criminal activity and being rewarded or praised for doing so, and thereby infer that this is an appropriate way of behaving. This theory probably makes the most sense for gangs and organized crime, where groups that engage in acts we'd normally find abhorrent such as robbery and murder nonetheless act according to a sort of "code" of social norms where individuals are expected to act in a certain way and serve the interests of their group.

Thursday, 22 August 2013

What is ascites? How does it affect cancer patients?





Related conditions:
late-stage cancer or liver disease, associated with ovarian, endometrial, breast, gastrointestinal (stomach, colon, pancreatic) cancer






Definition:
Ascites is an abnormal accumulation of excess fluid in the abdominal (peritoneal) cavity that causes swelling or bloating. In late-stage cancer, tumor cells may be isolated from the fluid. Ascites can also occur with liver disease.



Risk factors: Ascites is not uncommon in cancer patients; 15 to 50 percent develop this condition at some time during their illness. Ascites is most common in patients with
ovarian cancer but may also be present in patients with uterine, breast, colon, stomach, and pancreatic cancers. Liver involvement with cancer can increase the problem with ascites. Noncancerous conditions that can result in ascites include hepatitis, kidney failure, heart failure, and constrictive pericarditis (inflammation of the sac around the heart).



Etiology and the disease process: A lining of tissue, the peritoneum, supports the organs in the abdomen and covers the peritoneal cavity. Normally a small amount of body fluid lubricates this cavity and is kept in correct proportion by a pressure gradient. The liver stores blood and fluid depending on the pressure in the venous and arterial blood system. Under normal conditions, the lymphatic system drains 80 percent of the peritoneal fluid, so minimal accumulation occurs. When pathological or disease conditions occur, the fluid accumulates and edema settles in the peritoneal cavity.



In malignant ascites, a tumor may obstruct the lymphatic system so that drainage cannot occur. Liver involvement can cause a backup of fluid into the peritoneal cavity. In severe cases of ascites, gallons of liquid can fill the peritoneal cavity, pressing on the diaphragm (the muscles that separate the chest from the abdomen and allow a person to breathe).


Ascites is not actually a disease but a symptom of some pathological condition within the body. Some of the conditions that can result in ascites include cirrhosis of the liver (80 percent of ascites cases), pancreatic ascites, chylous ascites (a symptom of lymphoma), and cancer. Renal and endocrine ascites occur in rare instances.



Incidence: Approximately 10 percent of all cases of ascites occur in cancer patients. As many as half of all cancer patients will experience ascites. About 30 percent of all ovarian cancer patients have ascites, with as many as 60 percent presenting with ascites at death. Most cases result from disease that starts in the peritoneum or spreads from other body organs (metastasis).



Symptoms: Mild ascites may not be noticeable or present any symptoms. As the disease progresses, the abdomen can become more distended and swollen to the point of discomfort and pain. The patient may experience a feeling of heaviness. The patient may have trouble sitting, walking, or moving around. Fluid buildup may cause indigestion, nausea, or vomiting. The patient may experience diminished appetite with weight loss and general fatigue. When the fluid becomes excessive, the patient may have weight gain and shortness of breath. Some patients complain of swelling in the legs and ankles or experience hemorrhoids. Changes may occur in the navel as fluid collects. The severity of symptoms depends on the progression of the disease.



Screening and diagnosis: Diagnosis is confirmed using a physical exam and patient history along with X rays, ultrasound, computed tomography, or paracentesis with fluid analysis (removing fluid through a thin needle into the abdomen). Simple measuring of abdominal girth can provide a baseline for continued assessment.



Treatment and therapy: Treatment is targeted to the symptoms and to improve quality of life. One approach is to reduce sodium and fluid intake to decrease fluid buildup. Another is the use of diuretic drugs that promote removal of fluid through the kidneys as urination. Caution must be taken in the use of diuretics as the patient may experience hypovolemia (a drop in circulating blood volume through large loss of blood or fluid) with a severe drop in blood pressure or a potassium imbalance that can threaten the regular beat of the heart.


If discomfort is severe, a therapeutic paracentesis can be performed by the health care provider. This procedure drains fluid from the abdomen through a thin needle inserted into the peritoneal cavity. This procedure is generally performed with a local anesthesia. Rarely, surgery to shunt the fluid away from the abdominal cavity (peritoneovenous shunt) or specific chemotherapy may help. Repeated paracentesis as can be tolerated by the patient may be the only effective approach long term.


Few alternative or complementary approaches are effective for ascites. Diet can be modified to minimize sodium intake. The patient should consume potassium-rich foods such as low-fat yogurt, cantaloupe, or baked potatoes to assist with proper heart function.



Prognosis, prevention, and outcomes: The prognosis for ascites depends on the underlying cause and intensity of the problem. Generally, unless the cause is corrected, the fluid will return after draining with paracentesis. In fact, rapid reduction through the draining of fluid can result in rapid reaccumulation of fluid. Removing more than five liters at one time can result in hypotension, shock, and death.



Davis, Mellar P. Supportive Oncology. Philadelphia: Elsevier, 2011. Print.


Ginès, Pere, et al., eds. Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment. 2nd ed. Malden: Blackwell, 2005. Print.


Hawkins, Rebecca. “Clinical Focus: Ascites.” Clinical Journal of Oncology Nursing 5.1 (2001). Print.


Kiselevsky, Mikhail V. Malignant Effusions: Pleuritis, Ascites, Pericardites. Heidelberg: Springer, 2012. Print.


Yarbro, Connie Henke, Debra Wujcik, and Barbara Holmes Gobel. Cancer Symptom Management. 4th ed. Sudbury: Jones, 2014. Print.

How does Macbeth's obsession with the witches lead to his downfall?

When Macbeth discovers that he has become Thane of Cawdor just like the witches prophesied, he cannot help but dwell on the other part of the witches' prediction -- whether he will become the king of Scotland or not. However, Macbeth succumbs to the destructive power of his ambitions and takes matters into his own hands. He does not want to wait to become the king lawfully, instead, he is the one who wants to...

When Macbeth discovers that he has become Thane of Cawdor just like the witches prophesied, he cannot help but dwell on the other part of the witches' prediction -- whether he will become the king of Scotland or not. However, Macbeth succumbs to the destructive power of his ambitions and takes matters into his own hands. He does not want to wait to become the king lawfully, instead, he is the one who wants to fulfill the witches' prophecy. When he murders Duncan, we observe the beginning of his downfall. On the inside, he quickly becomes an unstable and vulnerable person, afraid he might lose his position as the king of Scotland. The reason for his unsettling thoughts lies in the fact that he feels threatened by the second part of the witches' prophecy, which states that Banquo's descendants will inherit the throne some day. This perturbs Macbeth greatly, and he begins to murder anyone who he thinks may jeopardize his position as the leader of the country.


Impatient to find out what awaits him in the future, he seeks out the witches and demands to find out what will happen. This shows how desperately dependent he has become on the witches because he does not want to allow nature to take its course. He wants to feel safe and immune to any threat and fear. However, his trust in the witches only shows how oblivious he is of the fact that their prophecy has a very destructive effect on him. He takes their words too literally, believing there is no such thing as a man not born of woman or woods that can move.


Although Macbeth is seduced by the witches' prophecy, the witches are not responsible for his downfall. They only sensed how corrupt he can become and encouraged such behavior. However, Macbeth's unbridled ambition is what makes him transform from a valiant and loyal subject to a treacherous and cold-blooded murderer.


How can a 0.5 molal solution be less concentrated than a 0.5 molar solution?

The answer lies in the units being used. "Molar" refers to molarity, a unit of measurement that describes how many moles of a solu...